| $MRK reports 1Q23 resultsraises non-GAAP EPS guidance: |
| @Cecil |
04/27/2023 1:08:25 PM |
| $MRK acquires RXDX for $10.8B |
| @rootsanalysis |
04/17/2023 4:37:16 PM |
| A Delaware judge ruled today that $MRK remains |
| @Crljeff |
04/03/2023 10:07:28 PM |
| Keytruda shows statsig-superior PFS as addend to chemo |
| @fdgeorge2 |
03/27/2023 9:52:42 PM |
| whytestocks: $MRK News Article - KEYTRUDA (pembrolizumab) Plus Chemotherapy Significantly Improved Overall Survi |
| @ |
03/10/2023 3:25:48 PM |
| whytestocks: $MRK News Article - Merck's Investigational Activin Signaling Inhibitor Sotatercept Improved Six-Min |
| @ |
03/06/2023 6:10:47 PM |
| EMA rejects $MRKs MAA for Molnipiravir: |
| @Lcarta |
02/24/2023 5:24:06 PM |
| whytestocks: $MRK News Article - Merck's KEYTRUDA (pembrolizumab) Plus Chemotherapy Met Primary Endpoint of Prog |
| @ |
02/03/2023 1:30:44 PM |
| whytestocks: $MRK News Article - Lung Cancer Market To Grow Steadily With An Impressive CAGR Of 14.4% From 2022 T |
| @ |
02/03/2023 1:25:46 PM |
| $MRK 4Q22 results2023 guidance: |
| @humbleinvestor |
02/02/2023 1:10:56 PM |
| FDA approves Keytruda for adjuvant NSCLC following adjuvant |
| @Avinvestor12 |
01/27/2023 3:25:43 PM |
| That would be the best , most productive |
| @catar |
01/27/2023 1:18:55 PM |
| Keytruda fails again in prostate cancerone of the |
| @camarodude04 |
01/25/2023 6:29:14 PM |
| Why |
| @Akshata |
12/29/2022 3:02:52 PM |
| The $MRK-SGEN deal reputed to be nearly done |
| @Entropik |
12/22/2022 4:14:13 PM |
| $MRK/MRNA cancer vaccine shines in adjuvant melanoma (RFS HR=0.56): |
| @ecraftindia |
12/13/2022 2:59:15 PM |
| whytestocks: $MRK News Article - Merck Enters Definitive Agreement to Acquire Imago Biosciences |
| @ |
11/21/2022 9:50:50 PM |
| MRK acquires $IMGO for $36.00/sh casha 107% premium |
| @Hash |
11/21/2022 1:36:42 PM |
| I would take the other side of that bet! |
| @jlavelle7 |
11/18/2022 8:44:46 PM |
| Ehhhhh seems a lot more likely today |
| @wesbriggs |
11/18/2022 8:44:12 PM |
| Unlikely, haha. |
| @Dick7285 |
11/18/2022 8:43:43 PM |
| $NWBO next purchase of Merck? |
| @aetmaad |
11/18/2022 8:36:16 PM |
| whytestocks: $MRK News Article - How Long Can This Top Stock Continue Defying the Bear Market? |
| @ |
11/17/2022 7:50:52 PM |
| whytestocks: $MRK News Article - Is Merck Too Dependent on Keytruda? |
| @ |
11/09/2022 6:10:51 PM |
| $MRK 3Q22 CC slides: |
| @lcraw2016 |
10/27/2022 4:26:02 PM |
| $MRK 3Q22 results: |
| @Cory3970 |
10/27/2022 1:25:30 PM |
| whytestocks: $MRK News Article - European Commission Expands Merck's VAXNEUVANCE(TM) (Pneumococcal 15-valent Conj |
| @ |
10/24/2022 4:15:50 PM |
| $MRK exercises option_to_commercialize$ MRNA cancer vaccine: |
| @john169 |
10/12/2022 3:26:58 PM |
| whytestocks: $MRK News Article - Guggenheim Upgraded the Merck Stock to Buy, Noting the Company's Projected Profi |
| @ |
10/10/2022 7:25:50 PM |
| whytestocks: $MRK News Article - Merck (MRK) Stock Jumps 4% on Positive Trial Data |
| @ |
10/10/2022 6:40:47 PM |
| Sotatercept phase-3 in PAH hits primary endpoint: |
| @Smithsix7 |
10/10/2022 4:23:38 PM |
| whytestocks: $MRK News Article - Merck Announces Positive Top-line Results from Pivotal Phase 3 STELLAR Trial Eva |
| @ |
10/10/2022 2:40:49 PM |
| Lagevrio misses_primary_endpoint_in_large_Oxford_U_trial: |
| @frankyvee |
10/07/2022 12:28:48 AM |
| whytestocks: $MRK News Article - Merck Animal Health to Acquire Vence |
| @ |
09/22/2022 3:20:47 PM |
| FDA allows some Islatravir trials to_resume_at_a lower dose: |
| @Solos |
09/20/2022 1:22:56 PM |
| Keytruda narrowly_misses_statsig OS/PFS as_addend_to Lenvina in_ first-line HCC: |
| @jordanjordancohen |
09/10/2022 7:00:45 PM |
| Merck snatched up ROR1 veslobio for 2.75 Billion |
| @Starstx |
08/18/2022 12:37:27 PM |
| Keytruda fails phase-3 in CRPC: |
| @mabdalla8 |
08/03/2022 3:59:54 PM |
| whytestocks: $MRK News Article - What Stocks To Buy Today? 5 Dividend Stocks To Watch In This Bear Market |
| @ |
07/11/2022 6:25:51 PM |
| FDA approves $MRKs pneumococcal vaccine, Vaxneuvance for infants/children: |
| @markdwane |
06/22/2022 11:22:56 AM |
| WHAT ARE YOU TALKING ABOUT??? COVID-19 IS |
| @Notsokojan |
06/19/2022 12:17:41 AM |
| Pay attention, looks like we have a change |
| @bigmike123 |
06/18/2022 11:31:45 PM |
| $MRK slides from ASCO webcast: |
| @hiwahiro |
06/07/2022 4:15:38 PM |
| Synopsis of (anti-LAG-3) favezelimab data from ASCO abstract: |
| @beackod |
05/26/2022 10:39:39 PM |
| whytestocks: $MRK News Article - Investors Shake off Hot Inflation Report |
| @ |
05/11/2022 8:10:55 PM |
| $MRK 1Q22 results: |
| @OGAnalysis |
04/28/2022 12:54:28 PM |
| CHMP approves Keytruda/chemo in the neoadjuvant setting followed |
| @GroenDigital |
04/25/2022 2:32:50 PM |
| $MRKs V116(follow-on_to Vaxneuvance)receives FDA BTD for prevention of |
| @Judes |
04/14/2022 1:59:20 PM |
| $MRKVaxneuvance sBLA for pediatrics gets 3-month extension to 7/1/22: |
| @rockhill |
04/01/2022 2:28:04 PM |
| FDA approves Keytruda monotherapy for recurrent endometrial cancer |
| @Krissy |
03/21/2022 9:47:34 PM |
| Thanks DewDiligence. The reason I ask, is that |
| @carmine01 |
03/20/2022 10:47:29 AM |
| Keytruda monotherapy-vs-placebo DFS HR=0.76 in adjuvant* NSCLC, irrespective |
| @JM4004 |
03/17/2022 9:08:39 PM |
| Thats a clerical error. |
| @fdgeorge2 |
03/17/2022 1:15:48 PM |
| Upon looking at Merck's Pipeline webpage I see |
| @amxxx |
03/17/2022 7:51:47 AM |
| COVID SCAM IS OVER... ALL THESE GRIFTER COMPANIES |
| @morokoy |
02/12/2022 1:23:57 AM |
| $MRK 4Q21 CC slides: |
| @Techsp |
02/03/2022 5:39:23 PM |
| $MRK 4Q21 results: |
| @GH12 |
02/03/2022 3:41:31 PM |
| whytestocks: $MRK News Article - European Commission Approves Merck's KEYTRUDA (pembrolizumab) as Adjuvant Thera |
| @ |
01/27/2022 7:00:54 PM |
| BIG PHARMA INCLUDING MERCK IN TROUBLE WITH $NEW |
| @jvsapu9728 |
01/08/2022 9:52:33 PM |
| India Won't Add Merck's COVID-19 Pill To National |
| @Nikko75 |
01/06/2022 6:04:05 PM |
| whytestocks: $MRK News Article - Showing Our Gratitude: Addressing COVID-19 Takes a Global Effort |
| @ |
01/05/2022 6:46:16 PM |
| BIG PHARMA RELYING UPON FRAUDULENT COVID-19 PCR TESTING |
| @DonArceri |
01/03/2022 5:53:36 PM |
| MERCK IS LATE TO THE PARTY, WITHOUT 94% |
| @scarter |
01/03/2022 5:36:22 PM |
| ISN'T IT INTERESTING HOW BIG PHARMA IS TAKING |
| @GreenGurly |
01/03/2022 5:31:54 PM |
| FDA grants EUA for $MRKs Molnupiravirwith_a_major_limitation: |
| @djsntspgr |
12/23/2021 2:54:33 PM |
| Mercks New Covid Pill Is a Disaster |
| @maryjoseph |
12/18/2021 3:12:31 PM |
| whytestocks: $MRK News Article - European Commission Approves Merck's VAXNEUVANCE(TM) (Pneumococcal 15-valent Con |
| @ |
12/15/2021 5:45:50 PM |
| whytestocks: $MRK News Article - Why You Can't Afford Not to Buy Merck's Stock |
| @ |
11/23/2021 8:05:50 PM |
| whytestocks: $MRK News Article - Techs, S&P Tumble to Start Week |
| @ |
10/04/2021 7:40:49 PM |
| whytestocks: $MRK News Article - A Glimpse of This Week's Earnings Calendar |
| @ |
10/04/2021 7:25:48 PM |
| znewcar1: That's awesome! MRK Monday! |
| @jethro77777 |
10/02/2021 1:07:36 PM |
| whytestocks: $MRK News Article - "The Buzz" Show: Merck (NYSE: MRK) Positive Data in Covid-19 Antiviral Drug Tria |
| @ |
10/01/2021 7:55:54 PM |
| whytestocks: $MRK News Article - Novavax News: Why NVAX Stock Investors Have a Tough Pill to Swallow Today |
| @ |
10/01/2021 4:35:51 PM |
| whytestocks: $MRK News Article - ACCELERON PHARMA ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of XLRN an |
| @ |
10/01/2021 4:05:51 PM |
| whytestocks: $MRK News Article - Dr Gottlieb on Merck's oral COVID-19 drug: 'it's a profound game changer' |
| @ |
10/01/2021 2:25:49 PM |
| whytestocks: $MRK News Article - Merck Announces Appointment of Thomas H. Glocer as Independent Lead Director |
| @ |
09/29/2021 8:10:49 PM |
| whytestocks: $MRK News Article - Top Biotech Stocks To Watch In October 2021 |
| @ |
09/29/2021 6:45:49 PM |
| whytestocks: $MRK News Article - Merck Completes Acquisition of Themis |
| @ |
06/19/2020 7:35:41 PM |
| EmergingGrowth: Zero Waste: https://emerginggrowth.com/itronics-inc-itro-nevada-grown-internationally-recognized |
| @ludovico |
06/17/2020 1:05:39 PM |
| whytestocks: $MRK News Article - FDA Accepts For Review Supplemental New Drug Application (sNDA) for RECARBRIO(TM |
| @ |
02/03/2020 9:55:41 PM |
| whytestocks: $MRK News Article - Is Merck Still a Strong Buy? |
| @ |
01/29/2020 9:45:43 PM |
| whytestocks: $MRK News Article - Merck's KEYTRUDA (pembrolizumab) Approved in Japan for Three New First-Line Ind |
| @ |
12/20/2019 5:05:43 PM |
| whytestocks: $MRK News Article - Merck's KEYTRUDA (pembrolizumab) Now Approved in China for First-Line Treatment |
| @ |
11/26/2019 9:20:42 PM |
| whytestocks: $MRK News Article - BRAVECTO PLUS (fluralaner and moxidectin topical solution) for Cats Receives Ap |
| @ |
11/15/2019 6:05:42 PM |
| whytestocks: $MRK News Article - Merck Fires on All Cylinders in Q3 With Soaring Sales for Keytruda |
| @ |
10/29/2019 7:45:43 PM |
| whytestocks: $MRK News Article - Dow Jones News: Walmart Under Pressure From Amazon; Merck Trounces Analyst Estim |
| @ |
10/29/2019 7:35:45 PM |
| whytestocks: $MRK News Article - Merck & Co Inc (MRK) Q3 2019 Earnings Call Transcript |
| @ |
10/29/2019 7:30:41 PM |
| whytestocks: $MRK News Article - S&P to Slip From Record High |
| @ |
10/29/2019 4:40:41 PM |
| whytestocks: $MRK News Article - Merck to Present at the 2019 Cantor Fitzgerald Global Healthcare Conference |
| @ |
09/30/2019 5:40:45 PM |
| whytestocks: $MRK News Article - Merck's KEYTRUDA (pembrolizumab) in Combination with Chemotherapy Met Primary E |
| @ |
07/29/2019 5:20:41 PM |
| whytestocks: $MRK News Article - European Medicines Agency Adopts Positive Opinion for Merck's KEYTRUDA (pembrol |
| @ |
07/29/2019 5:15:40 PM |
| whytestocks: $MRK News Article - Merck Foundation Announces Grant to American Cancer Society to Improve Access to |
| @ |
05/22/2019 6:35:40 PM |
| whytestocks: $MRK News Article - Merck Announces First-Quarter 2019 Financial Results |
| @ |
04/30/2019 6:05:40 PM |
| whytestocks: $MRK News Article - Merck and Viola Davis to Debut A Touch of Sugar During Tribeca Film Festival |
| @ |
04/25/2019 6:30:42 PM |
| riddock57: $MRK and $LLY To Test New Combo For Soft Tissue Sarcoma |
| @kathy |
01/13/2017 2:42:20 AM |
| Lucky Jimmy: MRK up +1.49% percent Today $MRK Stock High is at 53.26 and the Low 52.67 with current volume of 1,6 |
| @Art |
01/05/2016 4:49:08 PM |
| Hattlem: MRK buying Sirna Theraputics a baby in the RNAi field at the time it was purchased. Sirna traded on |
| @jdizzo8791 |
01/05/2016 10:38:36 AM |
| leahanne: Volume Alert - MRK Stock 51.87 Merck & Company $MRK Hit a high today of 52.15 Closing the day 12/21/ |
| @Jksr |
12/21/2015 10:42:12 PM |
| leahanne: Volume Alert - MRK Stock 51.64 Merck & Company $MRK Hit a high today of 52.32 Closing the day 12/18/ |
| @NancyMassicotte |
12/19/2015 2:16:47 AM |
| leahanne: Volume Alert - MRK Stock 52.66 Merck & Company $MRK Hit a high today of 54.25 Closing the day 12/17/ |
| @fxm474 |
12/18/2015 12:44:02 AM |